Sander Kersten, Cornell University, New York, USA, presents the evidence for the effects of loss of ANGPTL4 activity on triglyceride levels in liver and adipose tissue and discusses the implications for novel therapies targeting ANGPTL4.
Please login or create a FREE account to view this content
Educational Supporters of the 11th Closed Scientific Expert Meeting of the Editorial Board
Principal supporters:
Guest supporters:
